ELV — ELEVANCE HEALTH INC FORMERLY
Health Care · Healthcare Plans
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying ELV?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 3 tracked investors who changed their ELV position last quarter, 3 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 55/100 in a Squeeze regime). 1 congressional purchase, 0 sales disclosed in the last 6 months.
- +3 tracked investors added or increased positions last quarter (Paul Tudor Jones, Steve Cohen, Seth Klarman)
- +6 tracked investors reported holding ELV at their latest filing
- +Macro Health is 52/100 in a Squeeze regime — historically acceptable for Health Caresource
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/4/2026.
About ELEVANCE HEALTH INC FORMERLY (ELV)
ELEVANCE HEALTH INC FORMERLY (ELV) appears in the most recent 13F filings of 6 tracked institutional investors. ELEVANCE HEALTH INC FORMERLY is classified in the Health Care sector (Healthcare Plans industry). The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $555M. Across recent filings, tracked investors recorded 6 new positions, 1 increased, 1 reduced, and 1 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ELV
How many top investors track ELV
Several tracked investors have exposure.
ELV Ownership Composition
How ELEVANCE HEALTH INC FORMERLY is held across tracked investor types, based on reported 13F positions.
- Other98.0%
- Hedge Funds2.0%
Tracked investors reporting ELV
- Ken GriffinMar 31, 2026Citadel AdvisorsShares1.9MValue$554.7M% Portfolio0.09%
- Seth KlarmanMar 31, 2026Baupost GroupShares1.3MValue$373.3M% Portfolio7.30%
- Izzy EnglanderMar 31, 2026Millennium ManagementShares968.4KValue$283.5M% Portfolio0.12%
- Steve CohenMar 31, 2026Point72 Asset ManagementShares85.4KValue$25M% Portfolio0.03%
- Paul Tudor JonesMar 31, 2026Tudor Investment CorpShares49.3KValue$14.4M% Portfolio0.03%
- Ray DalioSep 30, 2025Bridgewater AssociatesShares55.2KValue$17.8K% Portfolio0.00%
Recent activity
- $13.7MFeb 17, 2026
- $14.4MMay 15, 2026
- New$19.9MFeb 17, 2026
- New$25MMay 15, 2026
- Increased$373.3M(0.46%)May 14, 2026
- Reduced$445M(-3.77%)Feb 13, 2026
- Sold$0(-100.00%)Feb 13, 2026
- New$426.2MNov 13, 2025
- New$17.8KNov 13, 2025
Frequently asked questions
- How many institutional investors hold ELV?
- 6 tracked institutional investors disclosed a position in ELV (ELEVANCE HEALTH INC FORMERLY) in their most recent 13F filing.
- Who is the largest institutional holder of ELV?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in ELV, valued at $555M.
- Did institutional ownership of ELV increase or decrease?
- Across recent 13F filings, tracked investors recorded 6 new positions, 1 increased, 1 reduced, and 1 fully exited ELV.
- What sector is ELV in?
- ELEVANCE HEALTH INC FORMERLY is classified in the Health Care GICS sector, Healthcare Plans industry.
- Where does this ELV ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.